Anthony Quinn
Director/Board Member at GENERATION BIO CO.
Net worth: 656 621 $ as of 2024-03-30
Network origin in Anthony Quinn first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 37 | |
Newcastle University
33
| College/University | Other Consumer Services | 33 |
Extinct | Biotechnology | 25 | |
Public Company | Biotechnology | 25 | |
Public Company | Pharmaceuticals: Major | 21 | |
University Of Dundee
18
| College/University | Other Consumer Services | 18 |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anthony Quinn via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | General Counsel Sales & Marketing Director/Board Member | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Public Communications Contact Corporate Officer/Principal | |
SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
DYAX CORP. | Pharmaceuticals: Major | Chief Administrative Officer Chief Executive Officer | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Director/Board Member Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Chief Executive Officer Private Equity Investor Private Equity Investor | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Director/Board Member Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Masters Business Admin Undergraduate Degree | |
The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Princeton University | College/University | Undergraduate Degree Corporate Officer/Principal | |
University of California San Diego | College/University | Graduate Degree Doctorate Degree | |
University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
THERMO FISHER SCIENTIFIC | Medical Specialties | Director of Finance/CFO Public Communications Contact | |
EPIZYME, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
Hong Kong Institution of Engineers
Hong Kong Institution of Engineers Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institution of Engineers operates as a professional membership organization. The non-profit company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Wing Hang Sit. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
VERASTEM, INC. | Biotechnology | General Counsel Director/Board Member | |
SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
AXCA HEALPAR | Biotechnology | Corporate Officer/Principal Founder Founder | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Compliance Officer | |
RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member Chief Executive Officer | |
KINIKSA PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Consultant / Advisor Corporate Officer/Principal | |
DYNE THERAPEUTICS, INC. | Biotechnology | Founder Chief Executive Officer Investor Relations Contact Founder Chief Tech/Sci/R&D Officer | |
MODERNA, INC. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal | |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Director/Board Member Founder | |
Inzen Therapeutics, Inc.
Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The private company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | Director/Board Member Director/Board Member | |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Founder | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistics
International
United States | 49 |
Denmark | 2 |
Hong Kong | 2 |
Sectoral
Health Technology | 34 |
Consumer Services | 11 |
Finance | 5 |
Commercial Services | 3 |
Retail Trade | 2 |
Operational
Director/Board Member | 475 |
Corporate Officer/Principal | 196 |
Independent Dir/Board Member | 143 |
Chairman | 89 |
Chief Executive Officer | 83 |
Most connected contacts
Insiders | |
---|---|
Noubar Afeyan | 75 |
Michael Bonney | 32 |
Thomas Tisch | 27 |
Theo Melas-Kyriazi | 26 |
Charles Rowland | 25 |
Justin Llewellyn Gareth Lewis | 25 |
Alison Lawton | 24 |
Jason Rhodes | 24 |
Stephen DiPalma | 24 |
Riyadh Salem Ali Ahmed Al-Edrissi | 22 |
V. Lawlis | 21 |
Benjamin Keswick | 21 |
Jeff Jonas | 21 |
Bonnie Bassler | 20 |
Andrew Peter Davison | 19 |
- Stock Market
- Insiders
- Anthony Quinn
- Company connections